Hal  Barron net worth and biography

Hal Barron Biography and Net Worth

Director of Quantinuum

Dr. Barron currently serves as CEO, Founder and Board Co-Chair of Altos Labs, a company focused on developing medicines to reverse age-related diseases by leveraging cell rejuvenation. He previously served as Chief Scientific Officer, and President of R&D at GSK, where he remains on the Board of Directors as a non-executive director. Prior to joining GSK, Dr. Barron was President, R&D at Calico Life Sciences, an Alphabet-funded company focused on aging, and before that, was Executive Vice President and Chief Medical Officer at both Roche and Genentech. Dr. Barron holds a B.S. in physics from Washington University School of Engineering in St. Louis and an M.D. from Yale University School of Medicine. He completed his training in Internal Medicine and Cardiology at the University of California, San Francisco, where he continues to serve as an adjunct professor.

What is Hal Barron's net worth?

The estimated net worth of Hal Barron is at least $16.05 million as of June 5th, 2026. Mr. Barron owns 255,833 shares of Quantinuum stock worth more than $16,053,521 as of June 18th. This net worth estimate does not reflect any other assets that Mr. Barron may own. Learn More about Hal Barron's net worth.

Has Hal Barron been buying or selling shares of Quantinuum?

Over the course of the past ninety days, Hal Barron has bought $15,000,000.00 in shares of Quantinuum stock. Most recently, on Friday, June 5th, Hal Barron bought 250,000 shares of Quantinuum stock. The stock was acquired at an average cost of $60.00 per share, with a total value of $15,000,000.00. Following the completion of the transaction, the director now directly owns 255,833 shares of the company's stock, valued at $15,349,980. Learn More on Hal Barron's trading history.

Who are Quantinuum's active insiders?

Quantinuum's insider roster includes Hal Barron (Director), and Eric Branderiz (Director). Learn More on Quantinuum's active insiders.

Are insiders buying or selling shares of Quantinuum?

In the last twelve months, Quantinuum insiders bought shares 11 times. They purchased a total of 411,032 shares worth more than $24,661,920.00. The most recent insider tranaction occured on June, 5th when Director Prineha Narang bought 200 shares worth more than $12,000.00. Learn More about insider trades at Quantinuum.

Information on this page was last updated on 6/5/2026.

Hal Barron Insider Trading History at Quantinuum

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2026Buy250,000$60.00$15,000,000.00255,833View SEC Filing Icon  
See Full Table

Hal Barron Buying and Selling Activity at Quantinuum

This chart shows Hal Barron's buying and selling at Quantinuum by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quantinuum Company Overview

Quantinuum logo
Read More

Today's Range

Now: $62.75
Low: $55.70
High: $65.60

50 Day Range

MA: N/A

2 Week Range

Now: $62.75
Low: $50.10
High: $71.35

Volume

3,656,681 shs

Average Volume

4,339,827 shs

Market Capitalization

$16.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A